Increased levels of hypothalamic neuronal nitric oxide synthase and vasopressin in salt-loaded Dahl rat.
The plasma concentration of arginine vasopression (AVP) and the expression level of the neuronal nitric oxide synthase (nNOS) gene in the paraventricular nucleus (PVN) and the Supraoptic nucleus (SON) of Sprague-Dawley (SD). Dahl salt-sensitive (S) and Dahl salt-resistant (R) rats on a high salt diet were examined by radioimmunoassay for AVP and in situ hybridization histochemistry for nNOS. The high salt diet containing 8.0% NaCl was given for 4 weeks. The concentrations of AVP in hypertensive Dahl S rats were significantly increased in comparison with those in SD rats and Dahl R rats on a high salt diet. The levels of nNOS mRNA and NADPH-diaphorase activity in the PVN and SON of hypertensive Dahl S rats were greater than those in Dahl R rats on a high salt diet. The antihypertensive drugs, either nicardipine or captopril were administered to the Dahl S rats for 2 weeks beginning 2 weeks after the start of the high salt diet The nNOS mRNA in the PVN and SON of Dahl S rats given a high salt diet was not upregulated by treatment with nicardipine, while the nNOS mRNA in salt loaded Dahl S rats was greater upregulated by treatment with captopril to that greater than without the antihypertensive drug. Our results suggest that the increased NO production in the PVN and SON of hypertensive Dahl S rats may be ineffective in decreasing blood pressure or inhibiting AVP secretion.
Serino
R
R
Department of Physiology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Ueta
Y
Y
Hanamiya
M
M
Nomura
M
M
Yamamoto
Y
Y
Yamaguchi
K I
KI
Nakashima
Y
Y
Yamashita
H
H
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology; D002216:Captopril / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects; D017403:In Situ Hybridization; D008297:Male; D009252:NADPH Dehydrogenase / Q000032:analysis / Q000378:metabolism; D009474:Neurons / Q000201:enzymology*; D009529:Nicardipine / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I; D009994:Osmolar Concentration; D010121:Oxytocin / Q000235:genetics; D010286:Paraventricular Hypothalamic Nucleus / Q000166:cytology / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D011863:Radioimmunoassay; D051381:Rats; D020303:Rats, Inbred Dahl; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000097:blood; D017673:Sodium Chloride, Dietary / Q000494:pharmacology; D013495:Supraoptic Nucleus / Q000166:cytology / Q000378:metabolism*; D014667:Vasopressins / Q000097:blood* / Q000235:genetics
D000959:Antihypertensive Agents; D012333:RNA, Messenger; D017673:Sodium Chloride, Dietary; D014667:Vasopressins; D010121:Oxytocin; D002216:Captopril; D012964:Sodium; D009529:Nicardipine; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat; D009252:NADPH Dehydrogenase